朱利叶斯·阿克塞尔罗德 (Julius Axelrod) 是一个著名的作家.

Stephen Pincock¹

¹stephenpincock@blueyonder.co.uk

Lancet (London, England)

|February 3, 2005

概括

No abstract available in PubMed .

相关概念视频

您也可能阅读

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Nature Index 2015 Collaborations.

Nature·2015

Same author

Sickle-cell disease.

Nature·2014

Same author

Hiroshi Nakajima.

Lancet (London, England)·2013

Same author

Publishing: Open to possibilities.

Nature·2013

Same author

Basil Hetzel: vanquishing iodine deficiency disorders.

Lancet (London, England)·2013

Same author

Linda Bearinger: creating healthy pathways for adolescents.

Lancet (London, England)·2012

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

查看所有相关文章

相关实验视频

朱利叶斯·阿克塞尔罗德 (Julius Axelrod) 是一个著名的作家.

相关概念视频

Nature Index 2015 Collaborations.

Sickle-cell disease.

Hiroshi Nakajima.

Publishing: Open to possibilities.

Basil Hetzel: vanquishing iodine deficiency disorders.

Linda Bearinger: creating healthy pathways for adolescents.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

朱利叶斯·阿克塞尔罗德 (Julius Axelrod) 是一个著名的作家.

相关概念视频

Nature Index 2015 Collaborations.

Sickle-cell disease.

Hiroshi Nakajima.

Publishing: Open to possibilities.

Basil Hetzel: vanquishing iodine deficiency disorders.

Linda Bearinger: creating healthy pathways for adolescents.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.